Country | 0–9 | 10–19* | 20–29 | 30+ | Median age of acquisition | ||||
---|---|---|---|---|---|---|---|---|---|
M | F | M | F | M | F | M | F | ||
*Only includes sera for 18–19 year olds in Germany. | |||||||||
Belgium | 69% | 69% | 47% | 47% | 38% | 28% | 20% | 16% | 15–19 |
Czech Republic | 57% | 56% | 36% | 29% | 16% | 17% | 6% | 5% | 5–9 |
Netherlands | 78% | 73% | 66% | 63% | 47% | 40% | 33% | 28% | 25–29 |
Finland | 92% | 94% | 86% | 81% | 78% | 72% | 46% | 38% | 30–34 |
Bulgaria | 38% | 40% | 23% | 16% | 15% | 12% | 8% | 8% | 5–9 |
Slovenia | – | – | – | 15% | – | 12% | – | 9% | – |
Germany | – | – | 40% | 38% | 35% | 30% | 14% | 9% | <15 |
England and Wales | 74% | 77% | 78% | 69% | 64% | 53% | 60% | 57% | >35 |